Curis, Inc. (CRIS)
0.8299
-0.05
(-5.62%)
USD |
NASDAQ |
Sep 25, 16:00
0.858
+0.03
(+3.39%)
After-Hours: 19:59
Curis Enterprise Value : -2.956M for Sept. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 25, 2026 | -2.956M |
| September 24, 2026 | -2.859M |
| September 23, 2026 | -2.718M |
| September 22, 2026 | -2.624M |
| September 21, 2026 | -2.674M |
| September 18, 2026 | -2.624M |
| September 17, 2026 | -2.449M |
| September 16, 2026 | -2.390M |
| September 15, 2026 | -2.371M |
| September 14, 2026 | -2.390M |
| September 11, 2026 | -2.371M |
| September 10, 2026 | -2.312M |
| September 09, 2026 | -2.234M |
| September 08, 2026 | -2.098M |
| September 04, 2026 | -1.942M |
| September 03, 2026 | -1.903M |
| September 02, 2026 | -1.883M |
| September 01, 2026 | -1.805M |
| August 31, 2026 | -1.669M |
| August 28, 2026 | -1.669M |
| August 27, 2026 | -1.650M |
| August 26, 2026 | -1.572M |
| August 25, 2026 | -1.474M |
| August 24, 2026 | -1.494M |
| August 21, 2026 | -1.494M |
| Date | Value |
|---|---|
| August 20, 2026 | -1.435M |
| August 19, 2026 | -1.221M |
| August 18, 2026 | -1.260M |
| August 17, 2026 | -1.065M |
| August 14, 2026 | -1.065M |
| August 13, 2026 | -0.9284M |
| August 12, 2026 | -1.318M |
| August 11, 2026 | -0.0708M |
| August 10, 2026 | 2.560M |
| August 07, 2026 | 3.262M |
| August 06, 2026 | 4.022M |
| August 05, 2026 | 4.285M |
| August 04, 2026 | 4.626M |
| August 03, 2026 | 5.464M |
| July 31, 2026 | 5.211M |
| July 30, 2026 | 5.094M |
| July 29, 2026 | 5.133M |
| July 28, 2026 | 4.841M |
| July 27, 2026 | 4.568M |
| July 24, 2026 | 4.958M |
| July 23, 2026 | 4.529M |
| July 22, 2026 | 5.055M |
| July 21, 2026 | 4.685M |
| July 20, 2026 | 4.236M |
| July 17, 2026 | 4.451M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 628.60M |
| Amgen, Inc. | 267.45B |
| Anika Therapeutics, Inc. | 259.45M |
| BioCryst Pharmaceuticals, Inc. | 2.676B |
| Imunon, Inc. | 7.560M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.581M |
| Total Expenses (Quarterly) | 8.581M |
| EPS Diluted (Quarterly) | -4.017 |
| Earnings Yield | -1.72K% |
| Normalized Earnings Yield | -3574.02 |